StudyRareStudyRare

Neuronal ceroid lipofuscinosis (Batten disease)

Log in to star

Last updated Nov 4, 2026

Log in to add personal notes on this page.

A school-age child develops progressive vision loss, seizures, and cognitive decline. Fundoscopy shows retinal degeneration.

Mostly AR (CLN4 disease, DNAJC5, is AD); 12 confirmed genes, among them PPT1 (CLN1), TPP1 (CLN2), CLN3, CLN5, CLN6, MFSD8 (CLN7), CLN8, and CTSD (CLN10). Loss-of-function variants; the common variant in each gene gives the classic phenotype, rarer milder ones a protracted course.

  • CLN3: Juvenile (classic Batten) - most common

Every NCL is a failure of lysosomal recycling: ceroid lipofuscin, a waste product of lipids and proteins, builds up in lysosomes, above all in neurons of the retina and brain. Nerve cells depend heavily on efficient recycling to survive throughout life, so they degenerate, giving the shared picture of vision loss, regression, dementia, epilepsy, and movement disorder. The gene sets the age of onset and the order of features.

  • Variants in PPT1 (CLN1): classic onset at 6 to 18 months, with vision lost later than other features. Granular osmiophilic deposits on electron microscopy.
  • Variants in TPP1 (CLN2): classic onset at 2 to 4 years with seizures and language delay. The enzyme is tripeptidyl peptidase 1, so recombinant enzyme (cerliponase alfa), given into the brain ventricles every 2 weeks, slows motor and language decline.
  • Variants in CLN3 (battenin): loss of function also disrupts trafficking, autophagy, and mitochondria. The retina is especially sensitive, so cone-rod dystrophy at 4 to 7 years comes first. Homozygosity for the common 1.02-kb deletion of exons 7 and 8 gives classic disease; it can be missed by exome or short-read genome sequencing. Missense variants with more residual function (p.Arg405Trp) can cause retinal degeneration alone.
mannose-6-phosphate receptorscarry the enzyme to the lysosomethe delivered hydrolases andlysosomal proteins: the PPT1enzyme, tripeptidyl peptidase 1,batteninPPT1, TPP1, CLN3; at acid pHneuronal ceroid lipofuscinosesmannose-6-phosphate exposedenzyme in thelysosomewaste broken downand recycled
Excerpt from lysosomal enzyme targeting and recycling. See the full pathway.

Part of lysosomal enzyme targeting and recycling.

Lysosomal degradation and recycling of cell waste; the NCL genes encode lysosomal enzymes (PPT1, TPP1) and other proteins that work in the lysosome (battenin).

worn-out cell lipids and proteins → lysosome → PPT1 enzyme (CLN1 disease), TPP1 enzyme (CLN2 disease), battenin (encoded by CLN3), or another NCL protein (the block) → recycled components

  • Accumulates: ceroid lipofuscin, with a gene-typical look on electron microscopy (granular osmiophilic deposits in CLN1, curvilinear profiles in CLN2, fingerprint bodies in the CLN3 form) and as vacuolated lymphocytes in the CLN3 form.
  • Missing: lysosomal recycling in neurons, which depend on it most.
  • Group of disorders with lipofuscin accumulation
  • Progressive vision loss (retinal degeneration)
  • Seizures
  • Cognitive and motor decline
  • Variable age of onset depending on subtype
  • Molecular testing of the CLN genes (panel) is the primary confirmatory test
  • Enzyme assays for the lysosomal forms: PPT1 (CLN1) and TPP1 (CLN2) activity in leukocytes/fibroblasts
  • Electron microscopy of tissue shows characteristic storage material (granular, curvilinear, or fingerprint profiles)
  • Cerliponase alfa (CLN2 disease)

Reference Links